Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer

NCT00039104 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

Adenocarcinoma of the Prostate
Recurrent Prostate Cancer
Stage IV Prostate Cancer

Interventions

DRUG: rebimastat
DRUG: zoledronic acid
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)